Your browser doesn't support javascript.
loading
68Ga-FAPI-04 PET/CT in Non-Small Cell Lung Cancer: Accurate Evaluation of Lymph Node Metastasis and Correlation with Fibroblast Activation Protein Expression.
Li, Chongjiao; Chen, Qiongrong; Tian, Yueli; Chen, Jie; Xu, Kui; Xiao, Zhiwei; Zhong, Juan; Wu, Jianyuan; Wen, Bing; He, Yong.
Afiliação
  • Li C; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Chen Q; Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China; and.
  • Tian Y; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Chen J; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Xu K; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Xiao Z; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Zhong J; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Wu J; Clinical Trial Centre, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Wen B; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • He Y; Department of Nuclear Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China; vincentheyong@163.com.
J Nucl Med ; 65(4): 527-532, 2024 Apr 01.
Article em En | MEDLINE | ID: mdl-38453362
ABSTRACT
Fibroblast activation protein (FAP) is a promising diagnostic and therapeutic target in various solid tumors. This study aimed to assess the diagnostic efficiency of 68Ga-labeled FAP inhibitor (FAPI)-04 PET/CT for detecting lymph node metastasis in non-small cell lung cancer (NSCLC) and to investigate the correlation between tumor 68Ga-FAPI-04 uptake and FAP expression.

Methods:

We retrospectively enrolled 136 participants with suspected or biopsy-confirmed NSCLC who underwent 68Ga-FAPI-04 PET/CT for initial staging. The diagnostic performance of 68Ga-FAPI-04 for the detection of NSCLC was evaluated. The final histopathology or typical imaging features were used as the reference standard. The SUVmax and SUVmean, 68Ga-FAPI-avid tumor volume (FTV), and total lesion FAP expression (TLF) were measured and calculated. FAP immunostaining of tissue specimens was performed. The correlation between 68Ga-FAPI-04 uptake and FAP expression was assessed using the Spearman correlation coefficient.

Results:

Ninety-one participants (median age, 65 y [interquartile range, 58-70 y]; 69 men) with NSCLC were finally analyzed. In lesion-based analysis, the diagnostic sensitivity and positive predictive value of 68Ga-FAPI-04 PET/CT for detection of the primary tumor were 96.70% (88/91) and 100% (88/88), respectively. In station-based analysis, the diagnostic sensitivity, specificity, and accuracy for the detection of lymph node metastasis were 72.00% (18/25), 93.10% (108/116), and 89.36% (126/141), respectively. Tumor 68Ga-FAPI-04 uptake (SUVmax, SUVmean, FTV, and TLF) correlated positively with FAP expression (r = 0.470, 0.477, 0.582, and 0.608, respectively; all P ≤ 0.001). The volume parameters FTV and TLF correlated strongly with FAP expression in 31 surgical specimens (r = 0.700 and 0.770, respectively; both P < 0.001).

Conclusion:

68Ga-FAPI-04 PET/CT had excellent diagnostic efficiency for detecting lymph node metastasis, and 68Ga-FAPI-04 uptake showed a close association with FAP expression in participants with NSCLC.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Ivermectina / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinolinas / Ivermectina / Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Limite: Aged / Humans / Male Idioma: En Ano de publicação: 2024 Tipo de documento: Article